Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Edinburgh Urological Cancer Group
Marie O'Donnell has not added Biography.
If you are Marie O'Donnell and would like to personalize this page please email our Author Liaison for assistance.
Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer.
The Journal of pathology Mar, 2002 | Pubmed ID: 11857492
Renal scarring caused by vesicoureteric reflux and urinary infection: a study in pigs.
Pediatric nephrology (Berlin, Germany) Jul, 2002 | Pubmed ID: 12172758
Ubiquitination of RIP1 regulates an NF-kappaB-independent cell-death switch in TNF signaling.
Current biology : CB Mar, 2007 | Pubmed ID: 17306544
The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response.
EMBO reports Sep, 2008 | Pubmed ID: 18636086
Chronicles of a death foretold: dual sequential cell death checkpoints in TNF signaling.
Cell cycle (Georgetown, Tex.) Mar, 2010 | Pubmed ID: 20237426
RIP1 comes back to life as a cell death regulator in TNFR1 signaling.
The FEBS journal Apr, 2011 | Pubmed ID: 21232018
Caspase 8 inhibits programmed necrosis by processing CYLD.
Nature cell biology Dec, 2011 | Pubmed ID: 22037414
NFκB and ubiquitination: partners in disarming RIPK1-mediated cell death.
Immunologic research Dec, 2012 | Pubmed ID: 22477525
NEMO inhibits programmed necrosis in an NFκB-independent manner by restraining RIP1.
PloS one , 2012 | Pubmed ID: 22848449
Stromal expression of decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in developing prostate and decreased levels of decorin in prostate cancer.
PloS one , 2012 | Pubmed ID: 22880013
Clinical Utility of an Epigenetic Assay to Detect Occult Prostate Cancer in Histopathologically Negative Biopsies: Results of the MATLOC Study.
The Journal of urology Sep, 2012 | Pubmed ID: 22999998
University of Edinburgh
Western General Hospital
Fiach C. O'Mahony1,
Jyoti Nanda1,
Alexander Laird1,
Peter Mullen2,
Helen Caldwell3,
Ian M. Overton4,
Lel Eory4,
Marie O'Donnell1,5,
Dana Faratian6,
Thomas Powles7,
David J. Harrison1,2,
Grant D. Stewart1
1Edinburgh Urological Cancer Group, University of Edinburgh,
2School of Medicine, University of St Andrews,
3Division of Pathology, University of Edinburgh,
4MRC Human Genetics Unit, MRC IGMM, University of Edinburgh,
5Department of Pathology, Western General Hospital,
6Breakthrough Breast Cancer Research Unit, University of Edinburgh,
7St Bartholomew's Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.